SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Barr Laboratory BRL -- Ignore unavailable to you. Want to Upgrade?


To: R Hamilton who wrote (124)9/2/1998 5:11:00 PM
From: Hong-Lee Yu  Respond to of 207
 
Two great news today; PREVIN as morning-after pill and Tamoxifen recommended for the prevention of breast cancer. If PREVIN can generate 50M sales annually, this alone will add 30-50C per share.

Watch out for analysts to up its estimates for 1999 earnings.